Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.

To provide optimum protection against classical and El Tor biotypes of Vibrio cholerae O1, a single-dose, oral cholera vaccine was developed by combining two live, attenuated vaccine strains, CVD 103-HgR (classical, Inaba) and CVD 111 (El Tor, Ogawa). The vaccines were formulated in a double-chamber...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Infect Immun
Asıl Yazarlar:	Taylor, D N, Tacket, C O, Losonsky, G, Castro, O, Gutierrez, J, Meza, R, Nataro, J P, Kaper, J B, Wasserman, S S, Edelman, R, Levine, M M, Cryz, S J
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1997
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175550/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9284163/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.65.9.3852-3856.1997
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.

Benzer Materyaller